For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Indevus Pharmaceuticals, Inc.

USPTO Granted Patents = 13

CIPO Patents = 4

Trademarks = 4

Forward Citations = 79

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Sandra Marie Jennings (3 out of 3 patents)

Thomas Joel Zupancic (3 out of 17 patents)

Joseph Cioffi (3 out of 12 patents)

4. Alan Wayne Shafer (3 out of 12 patents)

5. Timothy L Stuk (3 out of 28 patents)

6. H Ralph Snodgrass (3 out of 22 patents)

7. Petr Kuzma (2 out of 22 patents)

8. Cathryn M Clary (2 out of 2 patents)

9. Jeroen Van Beek (2 out of 2 patents)

10. Perry S Eisman (2 out of 2 patents)

11. Sean Donevan (2 out of 3 patents)

12. Atul Pande (2 out of 2 patents)

13. Richard Kavoussi (2 out of 2 patents)

14. Lyou-Fu Ma (2 out of 2 patents)

15. Robert B Zurier (2 out of 4 patents)

13 patents: Sort by Forward Citations

1. 7842303 - Long term drug delivery devices with polyurethane based polymers and their manufacture (2010-11-30),

2. 7553847 - Use of pagoclone for the treatment of social anxiety disorder (2009-06-30),

3. 7452868 - Controlled release formulations of octreotide (2008-11-18),

4. 7304158 - Method for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone) (2007-12-04),

5. 7057047 - Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2oxo-hexyl)-1-isoidolinone (2006-06-06),

6. 7026332 - Methods of treating obsessive-compulsive disorder (2006-04-11),

7. 6974835 - Methods for decreasing cell proliferation based on (3r,4r)-Δ8-tetrahydrocannabinol-11-oic acids (2005-12-13),

8. 6953670 - Methods for identifying compounds capable of supplementing the biological activity of leptin (2005-10-11),

9. 6949653 - Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone (2005-09-27),

10. 6914072 - Cannabinoid drugs (2005-07-05),

11. 6855721 - Methods and compositions for alleviating stuttering (2005-02-15),

12. 6838079 - Methods for using the obese product to stimulate hematopoietic development (2005-01-04),

13. 6524806 - Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 (2003-02-25),

Indevus Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapeutic products for urology, endocrinology, and men’s and women’s health. With a diverse product portfolio and a strong emphasis on research and development, Indevus aims to provide innovative solutions to meet the medical needs of patients. For more information about Indevus Pharmaceuticals and their products, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

13 Patents

#56 in Lexington, MA

#1,399 in Massachusetts

#23,104 in US

#43,644 in the World

Lexington, MA, United States of America

Indevus Pharmaceuticals, Inc.

Forward Citations = 79

21 inventors:

Sandra Marie Jennings (3 out of 3 patents)

Thomas Joel Zupancic (3 out of 17 patents)

Joseph Cioffi (3 out of 12 patents)

4. Alan Wayne Shafer (3 out of 12 patents)

5. Timothy L Stuk (3 out of 28 patents)

Please report any incorrect information to support@idiyas.com

Loading…